`

Tagged: plan and validation

With Biomarkers a routine part of drug development, BBCR assists companies with the identification and adoption of biomarkers, especially valuable in rare disease and precision medicine product development.

July 15th, 2024 | plan and validation

The FDA recognizes biomarker development as a high priority area for future research. BBCR can help your company with your product development plan and validation. BBCR is dedicated to supporting pharmaceutical innovators in the specialized rare diseases and orphan drug indications by developing and nurturing the product’s unique strengths. Our operational mission is to craft […]

With Biomarkers now a routine part of drug development, BBCR assists companies with the identification and adoption of biomarkers, especially valuable in rare disease and precision medicine product development.

September 22nd, 2021 | plan and validation

The FDA recognizes biomarker development as a high priority area for future research. BBCR can help your company with your product development plan and validation.  

Pin It on Pinterest